RT Journal Article
SR Electronic
A1 Nichols, Emma Hitt
T1 Bisoprolol Improves RVEF and Heart Rate in PAH
JF MD Conference Express
YR 2014
FD SAGE Publications
VO 14
IS 11
SP 21
OP 21
DO 10.1177/155989771411014
UL http://mdc.sagepub.com/content/14/11/21.abstract
AB Treatment of idiopathic pulmonary arterial hypertension (PAH) with the β-blocker bisoprolol resulted in decreased heart rate, increased right ventricular ejection fraction (RVEF), and improved quality of life. This article presents data from the Beta-Blocker Therapy in Idiopathic Pulmonary Arterial Hypertension trial [NCT01246037; Van Campen JSJA et al. Am J Respir Crit Care 2014].